Verax gains support for work on blood bacteria screening

10/10/2013 | MedCityNews.com

Verax Biomedical has secured $12 million to expedite the development of an advanced version of its assay for detecting bacteria in red blood cells before transfusions. The test could have applications in cellular therapies as well, according to the company.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID